Noticias de PFE_US
Noticias del mercado
Últimas noticias sobre PFE_US — 289 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
MFS Global Total Return Fund's Pfizer Inc(PFE) Holding History
Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study
Pfizer’s Ritlecitinib Trial Targets Painful Skin Disease, Adding Quiet Upside to PFE’s Pipeline
Pfizer posts late-stage trial win for multiple myeloma therapy Elrexfio
Pfizer's blood cancer drug meets main goal in late-stage trial
How Pfizer Inc. (PFE) Affects Rotational Strategy Timing
Pfizer Inc. $PFE Shares Acquired by First Fiduciary Investment Counsel Inc.
Cardinal Capital Management Takes Position in Pfizer Inc. $PFE
Pfizer (PFE) alcanzó los 26,48 dólares al cierre del último día de negociación, lo que refleja un cambio del -1,16% en comparación con su último cierre.
Pfizer Inc. stock underperforms Tuesday when compared to competitors
Hikma, Cipla Cut Deals In Pfizer Heart Drug Patent Case
Pfizer secures deals to keep heart drug free of generic rivals until 2031
Pfizer reaches settlement agreements with Dexcel Pharma, Hikma & Cipla for Vyndamax
Pfizer Stock Is Declining Today: What's Happening?
Should You Buy, Sell, or Hold Pfizer at $27?
Pfizer secures deals to keep heart drug free of generic rivals until 2031
Morgan Stanley reiterates Equalweight on Pfizer stock at $28
Pfizer’s Deal With Hikma Ends Patent Trial on Vyndamax Copy (1)
Página 8 de 15
